Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients

被引:136
作者
Kasperska-Zajac, A. [1 ]
Sztylc, J. [1 ]
Machura, E. [2 ]
Jop, G. [1 ]
机构
[1] Med Univ Silesia, Clin Dept Internal Dis Allergol & Clin Immunol, Katowice, Poland
[2] Med Univ Silesia, Dept Pediat Zabrze, Katowice, Poland
关键词
acute-phase response; chronic urticaria; C-reactive protein (CRP); IL-6; systemic inflammation; CHRONIC IDIOPATHIC URTICARIA; MAST-CELL; BLOOD-COAGULATION; SKIN-TEST; INTERLEUKIN-6; INFLAMMATION; MATRIX-METALLOPROTEINASE-9; ACTIVATION; MARKERS;
D O I
10.1111/j.1365-2222.2011.03789.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background Our previous study was the first to demonstrate enhanced plasma IL-6 concentrations in chronic urticaria (CU). It is known that C-reactive protein (CRP) is a sensitive marker of an underlying systemic inflammation, triggered mainly as a response to IL-6. Objective To evaluate plasma IL-6 concentration in CU patients relating to the clinical disease activity and serum CRP concentration. Methods Serum CRP and plasma IL-6 concentrations were measured in 58 CU patients and 30 healthy subjects. Ten CU patients were evaluated twice, during the active period as well as upon the spontaneous clinical remission of the disease. CU activity was assessed with the use of the symptom scores recommended by EAACI/GALEN/EDF guidelines. Results IL-6 and CRP concentrations were significantly increased in CU patients as compared with the healthy subjects, whereas they decreased remarkably upon the spontaneous remission. IL-6 concentration was associated with weekly urticaria activity scores and also significant differences were found between patients showing different degrees of urticarial activity. Significant correlation was observed between IL-6 and CRP concentrations. Conclusions and Clinical Relevance This study reinforces evidence that, apart from a local cutaneous inflammation, CU is associated with a systemic inflammatory response. Such acute-phase response is manifested by increased circulating IL-6, which varies along with CRP changes and may be related to the urticarial activity.
引用
收藏
页码:1386 / 1391
页数:6
相关论文
共 22 条
[1]   Matrix metalloproteinase-9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients? [J].
Altrichter, S. ;
Boodstein, N. ;
Maurer, M. .
ALLERGY, 2009, 64 (04) :652-656
[2]   Severe chronic urticaria is associated with elevated plasma levels of D-dimer [J].
Asero, R. ;
Tedeschi, A. ;
Riboldi, P. ;
Griffini, S. ;
Bonanni, E. ;
Cugno, M. .
ALLERGY, 2008, 63 (02) :176-180
[3]   Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria [J].
Asero, Riccardo ;
Tedeschi, Alberto ;
Coppola, Raffaella ;
Griffini, Samantha ;
Paparella, Paolo ;
Riboldi, Piersandro ;
Marzano, Angelo V. ;
Fanoni, Daniele ;
Cugno, Massimo .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (03) :705-710
[4]  
Cugno M, 2009, EXPERT REV CLIN IMMU, V5, P605, DOI [10.1586/eci.09.40, 10.1586/ECI.09.40]
[5]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[6]   Up-regulation of IL-6 mRNA in peripheral blood mononuclear cells of patients with acute urticaria [J].
Fujii, K ;
Ohgou, N .
JOURNAL OF DERMATOLOGY, 2004, 31 (03) :242-243
[7]   Acute urticaria with elevated circulating interleukin-6 is resistant to anti-histamine treatment [J].
Fujii, K ;
Konishi, K ;
Kanno, Y ;
Ohgou, N .
JOURNAL OF DERMATOLOGY, 2001, 28 (05) :248-250
[8]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[9]   Interleukin-6 and chronic inflammation [J].
Gabay, Cem .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (Suppl 2)
[10]  
Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5